Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Motionstræning hos kvinder med hjertesygdom 2 (EXCEED2)

30. september 2026 opdateret af: Ottawa Heart Institute Research Corporation

Motionstræning hos kvinder med hjertesygdom: et randomiseret kontrolleret forsøg

This study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity continuous training (MICT). After randomization, patients will exercise twice a week, for 12 weeks. The sessions will be conducted virtually. Patients will undergo a maximal exercise test, cardiometabolic indicators (height (cm), body mass (kg), body composition (%), waist circumference (cm) and, resting blood pressure) and complete questionnaires about quality of life, mental health, self-determined motivation, self-efficacy and enjoyment.

Studieoversigt

Status

Rekruttering

Intervention / Behandling

Detaljeret beskrivelse

Heart disease is a leading cause of death for women. Women who suffer a heart attack are more likely than men to be inactive, have lower fitness, and die in the next year; patients also report poor mental health and quality of life (QoL), and have a greater risk of cardiovascular disease risk factors. This clinical research project is concerned about women with heart disease and how to improve their fitness, mental health, and QoL using a different kind of exercise. Currently, moderate-to-vigorous intensity continuous training, MICT, is the most frequently prescribed for women with heart disease. Unfortunately, this exercise tends to be a burden and is time-consuming. The study aims to test if high-intensity interval training (HIIT, alternating periods of hard exercise and rest) is better than MICT at improving fitness, mental health, QoL, and exercise dedication in women with heart disease. The investigators will recruit 104 women with heart disease. The investigators will first assess the health measures outlined above and then randomly assign people to MICT or HIIT. Both groups will attend virtual exercise sessions 2 days/week for 12 weeks. The MICT group will perform Zumba/movement-based exercise for 35 minutes at an intensity level of 70-85% of their maximal effort. The HIIT group will perform Zumba/movement-based exercise for 25-minutes: this will consist of 4 periods of exercising for 4-minutes at an intensity level of 85-95% of their maximal effort, separated by 3 minutes of rest between each period. The investigators will assess the health measures again after 12 and 26 weeks. The scores for people in the two groups will then be compared. HIIT has never been evaluated as an alternative for MICT in a large women-only group with heart disease. If this clinical trial shows that HIIT helps these women improve their physical and psychosocial health over usual practice, then health care professionals caring for women with heart disease will have an alternative, effective treatment option to provide women in need.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

172

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Ontario
      • Ottawa, Ontario, Canada, K1Y 4W7
        • Rekruttering
        • University of Ottawa Heart Institute
        • Kontakt:
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  1. Women (i.e., female sex assigned at birth) with CHD (e.g., coronary artery bypass grafting surgery [CABG], percutaneous coronary intervention [PCI], acute myocardial infarction [MI], MI with no obstructive coronary artery disease [MINOCA], or ischemia with no obstructive coronary artery disease [INOCA] at least 4 weeks post procedure or event; based on clinical evidence this is a safe period of time to exercise);
  2. Patient is able to perform a symptom limited CPET (this is the primary outcome and needed to determine peak HR for the exercise training prescription); and
  3. Patient is able to read and understand English or French.

Exclusion Criteria:

  1. Patient is currently participating in routine exercise training (>2x/week, routine exercise training is defined as a planned, structured, and repetitive exercise that is performed in order to maintain or improve physical fitness.) (this may reduce the impact of HIIT or MICT on outcomes);
  2. Patient has: NYHA class III-IV heart failure symptoms; unstable angina; or established diagnosis of chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy (this may interfere with the ability to engage in MICT or HIIT);
  3. Patient has uncontrolled arrhythmia (this may impact the HR-based exercise training prescription and monitoring);
  4. Patient is unable to provide written informed consent; or
  5. Patient is unwilling or unable to return for follow-up visits at 12 and 26 weeks.
  6. Patient is unwilling to be randomized to HIIT or MICT.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: standard care + moderate-intensity continuous exercise training

2 days/week Warm-up: 60-70% peak HR - 10min Training: 70-85% peak HR - 35min Cool-down: 60-70% peak HR - 15min

The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.

Eksperimentel: standard care + high-intensity interval training

2 days/week Warm-up: 60-70% peak HR - 10min Training: 85-95% peak HR - 25 minutes (4x4-minutes of high-intensity intervals interspersed with 3 minutes of low-intensity intervals) Cool-down: 60-70% peak HR - 10min

The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Exercise capacity
Tidsramme: from baseline to week-6 and from baseline to week-12

will be measured using a gold standard symptom-limited, cardiopulmonary exercise test (CPET) on a treadmill (or on an alternate equipment, such as a cycle ergometer or recumbent bike). Gas exchange will be monitored continuously (- Parvo Medics TrueOne® 2400); the highest 20 second average rate of oxygen uptake achieved (i.e. peak VO2 in mL/kg/min) during the last minute of the CPET will represent exercise capacity.

from baseline to week-6 and from baseline to week-12

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
physical and mental health
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

hysical and mental health will be measured using the Mental Health Composite Scale (MCS) and Physical Composite Scale (PCS) of the Short Form-36 questionnaire. It consists of 36 items that contribute to eight subscales summarized into a physical component summary scale (PCS) and a mental component summary scale (MCS). A higher score on a 0-100 scale indicates a better quality of life.

from baseline to 12 weeks and baseline to 26 weeks
Disease-specific Quality of Life, global health, physical and emotional health
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

measured using the HeartQoL, a validated 14-item questionnaire that assesses patients' feelings on how heart disease affects daily functioning, providing a global-health related QoL score and physical and emotional subscales. Higher score means better quality of life. Score range from 0-3, where higher scores represents better heart quality of life.

from baseline to 12 weeks and baseline to 26 weeks
Anxiety symptoms
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

assessed with the Generalized Anxiety Disorder-7 (GAD-7).Participants rate statements regarding symptoms of anxiety on a 4-point scale (0=not at all; 4=nearly every day). The items are summed to obtain a score ranging from 0-21.

from baseline to 12 weeks and baseline to 26 weeks
Depressive symptoms
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

Depressive symptoms: assessed with the Patient Health Questionnaire (PHQ-9), a 9-item scale based on diagnostic criteria for depressive disorders. Participants rate statements on a 4-point scale (0=not at all; 4=nearly every day), yielding a single score indicating severity of depression symptoms.

from baseline to 12 weeks and baseline to 26 weeks
body composition - BMI
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

body mass (kg) and height (cm) will be measured to calculate body mass index (kg/m^2)

from baseline to 12 weeks and baseline to 26 weeks
body composition - Waist circumference
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

Changes in body composition from baseline to 12 weeks and baseline to 26 weeks are measured by waist circumference (cm).

from baseline to 12 weeks and baseline to 26 weeks
body composition - BIA
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

Changes in body composition from baseline to 12 weeks and baseline to 26 weeks are measured by bioelectrical impedance (%)

from baseline to 12 weeks and baseline to 26 weeks
Vital Signs - Resting Blood Pressure
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

changes in vital signs will be measured using resting blood pressure (mmHg) in a seated position after a 5-minute rest period on the right arm using an automated monitor (BPTru) that measures 3 times at 2-minute intervals.

from baseline to 12 weeks and baseline to 26 weeks
Vital Signs - Resting Heart Rate
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

changes in vital signs will be measured using resting heart rate (bpm)

from baseline to 12 weeks and baseline to 26 weeks
Self-determined motivation for exercise
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

the 24-item Behavioural Regulation in Exercise questionnaire (BREQ-3) yields an overall Relative Autonomy Index (RAI) score, representing overall self-determined motivation. The scale ranges from -3 "amotivation to +3 "intrinsic regulation".

from baseline to 12 weeks and baseline to 26 weeks
Overall self-efficacy for exercise
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

the 9-item Multidimensional Self-Efficacy for Exercise Scale (MSES-R) yields an overall self-efficacy for exercise score reflecting scheduling, task and coping self-efficacy. The MSES consists of nine items on a 100% confidence scale ranging from 0 = "no confidence" to 100 = "completely confident."

from baseline to 12 weeks and baseline to 26 weeks
physical activity enjoyment
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

the 18-item Physical Activity Enjoyment Scale (PACES) measures the extent (on a 7-point Likert scale) to which participants enjoy doing physical activity. Overall enjoyment for physical activity score is determined by summing the items, with a range of 18-126 being possible. Higher scores indicate higher enjoyment.

from baseline to 12 weeks and baseline to 26 weeks
Gender
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

assessed using the Genesis-Praxy questionnaire.

from baseline to 12 weeks and baseline to 26 weeks

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Physical activity levels
Tidsramme: from baseline to 12 weeks and baseline to 26 weeks

will be measured objectively. The ActiGraph wGT3X-BT accelerometer (ActiGraph, Pensacola, Florida) will be worn over the right hip for 7 days

from baseline to 12 weeks and baseline to 26 weeks
Program compliance
Tidsramme: from baseline to 12 weeks

Staff will record the number of MICT or HIIT sessions attended over the 12-week period (attended/prescribed x 100 = % compliance). Staff will record the number of MICT or HIIT sessions attended over the 14 weeks of unsupervised virtual exercise session.

Reasons for missing exercise sessions and program drop-out will be collected to inform the development of strategies to engage women in CR.

from baseline to 12 weeks
Participant Experience
Tidsramme: at 12 weeks

As per the ORBIT model166 for developing effective behavioural treatments for chronic diseases, semi-structured focus groups (N=4)167 with patients (N=20, purposively selected according to age, gender, and medical conditions)168 will be conducted at 12 weeks to explore factors influencing adherence and satisfaction with MICT or HIIT. Each focus group will be 60-90 minutes in duration and will be held at times convenient for the participants

at 12 weeks
Feeling Scale
Tidsramme: during intervention

To assess affective response during exercise, the Feeling Scale will be completed during and immediately post exercise. The patient will report the value in a one-on-one chat function. The FS is an 11-point, single-item, bipolar rating scale commonly used for the assessment of affective valence (i.e., please-displeasure) during exercise. The scale ranges from -5 ("Very Bad") to +5 ("Very Good").

during intervention
Participant Feedback
Tidsramme: from baseline to 12 weeks

To assess the participant's experience using a virtual intervention method.

from baseline to 12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Jennifer Reed, PhD, Ottawa Heart Institute Research Corporation

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

27. januar 2025

Primær færdiggørelse (Anslået)

31. december 2028

Studieafslutning (Anslået)

30. marts 2029

Datoer for studieregistrering

Først indsendt

2. juli 2024

Først indsendt, der opfyldte QC-kriterier

2. juli 2024

Først opslået (Faktiske)

10. juli 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner